Min Gyeong Kang

This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignee: Cj Cheiljedang Corporation. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Gyeong Kang. Retrieved from https://idiyas.com/inventor/min-gyeong-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

6 out of 972

Cj Cheiljedang Corporation

patents

Years Active: 2019-2022

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11492648 - Modified polypeptide having an activity of ornithine-based product exporter and method for producing ornithine-based product using cells expressing the polypeptide (2022-11-08),

2. 11345940 - Microorganism of genusproducing L-arginine and method for producing L-arginine using the same (2022-05-31),

3. 10870871 - Polypeptide and method for producing ornithine-based product using the same (2020-12-22),

4. 10696990 - Variant of O-phosphoserine exporter and method of producing O-phosphoserine, cysteine, and its derivatives using the same (2020-06-30),

5. 10626426 - Microorganism of genushaving an ability to produce L-arginine and a method for producing L-arginine using the same (2020-04-21),

6. 10266858 - [object Object] (2019-04-23),

Title: Inventor Min Gyeong Kang: Pioneering Innovations in Biotechnology

Introduction

Min Gyeong Kang is a prominent inventor based in Seoul, South Korea. With a total of six patents to his name, he has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and microorganisms.

Latest Patents

Among his most recent innovations, Min Gyeong Kang has filed patents for a modified polypeptide that facilitates the export of ornithine-based products. This novel polypeptide provides a new method for producing ornithine-based products utilizing cells that express the polypeptide. Additionally, he has developed a microorganism from a specific genus that produces L-arginine, alongside a method for producing this important amino acid.

Career Highlights

Min Gyeong Kang is currently associated with CJ CheilJedang Corporation, a leading food and biotechnology company known for its innovative approaches in the industry. His work has not only advanced scientific understanding but also practical applications in biotechnology and medicine.

Collaborations

Throughout his career, Min Gyeong Kang has collaborated with esteemed colleagues, including Hye Won Kim and Han Hyoung Lee. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their research in the field.

Conclusion

The innovations developed by Min Gyeong Kang represent a significant step forward in biotechnology. His dedication to advancing knowledge and practical applications continues to inspire many in the scientific community. As research in these areas progresses, his contributions are likely to play a crucial role in future developments.

Profile summary based on public USPTO records.